Sight Sciences, Inc.

NASDAQ:SGHT

Medical - Devices

Healthcare
$10.62 +2.89%

+$0.15 today

Market cap
$590.25M
Beta
2.41
P/E (TTM)
-7.5
EPS (TTM)
-$0.69
52W Low $3.11High $9.24

Volume 0.38M

Average 0.25M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$29.69M

FY 2025 · Annual

Investing Cash Flow

-$224,000.00

FY 2025 · Annual

Financing Cash Flow

$1.79M

FY 2025 · Annual

-63.9% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(62.96M)(86.24M)(55.55M)(51.51M)(38.43M)
Depreciation & Amortization632K710K614K712K487K
Deferred Income Tax7.76M0000
Stock-Based Compensation5.08M12.96M14.58M17.08M13.05M
Change in Working Capital(4.33M)(5.7M)(9.13M)9M(6.4M)
Accounts Receivables(3.69M)(6.84M)661K3.55M912K
Inventory(1.31M)(3.25M)(2.16M)1.63M(1.44M)
Accounts Payables1.17M(694K)(883K)336K(348K)
Other Working Capital(486K)5.09M(6.76M)3.49M(5.52M)
Other Non-Cash Items1.27M2.3M2.3M2.37M1.59M
Operating Cash Flow(52.54M)(75.97M)(47.18M)(22.35M)(29.69M)
Capital Expenditures(813K)(970K)(791K)(385K)(224K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(813K)(970K)(791K)(385K)(224K)
Debt Repayment0004.15M0
Common Stock Issued256.68M1.25M1.33M1.07M1.85M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(4.15M)1.25M(224K)(261K)(58K)
Financing Cash Flow252.53M1.25M1.1M4.96M1.79M
Effect of Forex Changes00000
Net Change in Cash199.18M(75.69M)(46.87M)(17.77M)(28.13M)
Free Cash Flow(53.35M)(76.94M)(47.98M)(22.74M)(29.92M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$38.4M
+ D&A$487.0K
+ Stock-Based Comp$13.1M
+ Deferred Tax$0
- Working Capital-$6.4M
+ Other Non-Cash$1.6M
= Operating Cash Flow-$29.7M
- Capex-$224.0K
= Free Cash Flow-$29.9M

Analysis

FY2025 free cash flow is -$29.9M. FCF conversion is 77.9% of net income. Operating cash flow was -$29.7M, with capex of -$224.0K. The largest bridge item is Stock-Based Comp at $13.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
4Statement of changes in beneficial ownershipOct 5, 2026
4Statement of changes in beneficial ownershipOct 5, 2026
4Statement of changes in beneficial ownershipOct 5, 2026

Does SGHT generate free cash flow?

Sight Sciences, Inc. (SGHT) generated -$29.92M of free cash flow in fiscal 2025.

How much operating cash flow does SGHT produce?

Operating cash flow was -$29.69M, before capital expenditures of $224,000.00.